Management Review
Management review is the formal, periodic mechanism by which senior management evaluates the pharmaceutical quality system’s performance — using quality metrics, audit results, and CAPA effectiveness as inputs — and commits resources and direction in response. It is the governance layer that keeps a quality system from operating as a paperwork exercise disconnected from business decision-making.
What an explainer is not
A topic explainer is SPEQ’s synthesis of what a practice involves, cited to the standards that govern it. It does not reproduce their text, and it does not determine which of them apply to your product or process.
[ POSITION IN THE FRAMEWORK ]
7 DIMENSIONS · 21 LINKSManagement review is the only mechanism that converts quality data into resources, so its real output is not the minutes — it is a decision that costs somebody something.
06 · QUALITY MATURITY — MANAGEMENT REVIEW, REACTIVE TO ADAPTIVE
A meeting happens because the procedure requires one. The pack is assembled the week before and read in the room.
A standing agenda covers the required inputs and minutes record attendance and topics, but no output is traceable to a resource or a priority changing.
Each review produces owned actions with dates and resources attached, and the following review opens on what happened to them.
Topics reach the agenda because the data raised them, not because the template lists them, and unwelcome items survive to the room.
Quality performance is a standing input to how the business allocates money and people, and the review is where that allocation is visibly contested.
SPEQ’s shared five-stage progression, labelled synthesis — not the FDA QMM rating scale. Where does your organization sit? Score your quality system →
07 · REGULATORY & EVIDENCE
GOVERNING STANDARDS · 3
Derived from the 3 standards SPEQ maps to this subject, across 2 regulatory bodies: ICH, ISO.
RECORDS & OBJECTIVE EVIDENCE
- The review schedule and attendance, showing which executives were present
- Input packs for the last several cycles, with the data as it was presented
- Actions arising, with owners, dates and the resource decision attached to each
- Evidence of closure, and of items carried forward with the reason
- The escalation route by which an urgent issue reaches this forum between cycles
COMMON INSPECTION FINDINGS
- Reviews held without the people who can commit resources in the room
- Actions recorded without an owner, a date, or any evidence of closure
- The same issue reappearing across cycles with no change in what is being done about it
- Inputs limited to the template while a known systemic problem was never tabled
- Long gaps between reviews with no interim escalation route defined
What Management Review Is For
ICH Q10 names management review of the pharmaceutical quality system as one of the enablers that keeps the PQS effective across the product lifecycle: it is where senior management looks at aggregated quality performance — not a single deviation or a single batch — and decides whether the system needs more resource, different priorities, or structural change.
ISO 9001 and ISO 13485 both codify management review as a mandatory clause with defined required inputs and outputs, which is why the practice is recognisable across pharma, device, and general quality-management contexts even though the regulatory language differs.
Typical Inputs
A credible management review draws on trended data, not anecdote: CAPA status and effectiveness, audit and inspection findings, customer complaints, process and product performance indicators, the status of previous management-review actions, and any regulatory or business changes bearing on the quality system.
Product Quality Review output is a common feed into management review at the product level, while site- or organisation-level quality metrics roll up across products — the two operate at different altitudes but both belong in the same review.
Required Outputs
ISO 9001 and ISO 13485 both require management review to produce decisions and actions: on opportunities for improvement, on any need to change the quality management system, and on resource needs. A review that produces minutes but no resourcing decision or documented action has not met the intent of the requirement.
Frequency and Escalation
Most organisations run management review on a fixed cadence — commonly quarterly at the operational level and annually at the executive level — but a credible PQS also has an escalation path that can trigger an unscheduled review when a signal (a critical recall, a repeated inspection finding, a cluster of related deviations) cannot wait for the next scheduled cycle.
SPEQ interpretation: the review’s value is proportional to how much unfiltered signal reaches the table. A review package that has been pre-summarised into “green/amber/red” status without the underlying trend data lets management approve a narrative rather than confront the actual pattern.
FREQUENTLY ASKED
Is management review the same thing as a quality council meeting?
Many organisations use “quality council” as the operational name for the recurring meeting that fulfils the management-review requirement, but the label is not the point — what matters is that the defined inputs are reviewed and the defined outputs (decisions, resource commitments, actions) are documented.
Who is required to attend management review?
ISO 9001, ISO 13485, and ICH Q10 all place the accountability with “senior management” or “top management” — the individuals with authority to commit resources and set direction — rather than delegating the review entirely to the quality function.
How is management review different from a CAPA effectiveness check?
A CAPA effectiveness check evaluates whether one corrective action solved the problem it targeted. Management review looks across all CAPAs, deviations, and quality indicators together to judge whether the quality system as a whole is performing and adequately resourced.